发明公开
EP0605913A1 Use of bile salt-activated lipase as dietary supplement
失效
Verwendung vonGallsäure-aktiviertem Lipase alsDiätsupplement。
- 专利标题： Use of bile salt-activated lipase as dietary supplement
- 专利标题（中）： Verwendung vonGallsäure-aktiviertem Lipase alsDiätsupplement。
-
申请号： EP93203480.4申请日： 1988-11-18
-
公开(公告)号： EP0605913A1公开(公告)日： 1994-07-13
- 发明人: Tang, Jordan J. N. , Wang, Chi-Sun
- 申请人： Oklahoma Medical Research Foundation
- 申请人地址： 825 N.E. 13th Street Oklahoma City Oklahoma 73104 US
- 专利权人： Oklahoma Medical Research Foundation
- 当前专利权人： Oklahoma Medical Research Foundation
- 当前专利权人地址： 825 N.E. 13th Street Oklahoma City Oklahoma 73104 US
- 代理机构： Bassett, Richard Simon
- 优先权： US122410 19871119
- 主分类号： A61K37/54
- IPC分类号： A61K37/54 ; A23L1/03
摘要：
A method is provided to treat subjects for inadequate pancreatic enzyme production by administration of bile salt-activated lipase in conjunction with ingestion of fats. The bile salt-activated lipase is provided in a dosage providing at least 1 mg lipase/2000 mg ingested fat.
公开/授权文献
- EP0605913B1 Use of bile salt-activated lipase as dietary supplement 公开/授权日：2000-10-25
信息查询
